|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
SGO Clinical Practice Endometrial Cancer
Working Group, ; Burke WM, Orr J, Leitao M, Salom E, Gehrig P,
Olawaiye AB, Brewer M, Boruta D, Villella J, et al: Endometrial
cancer: A review and current management strategies: Part I. Gynecol
Oncol. 134:385–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho CM, Chien TY, Huang SH, Wu CJ, Shih BY
and Chang SC: Multivariate analysis of the prognostic factors and
outcomes in early cervical cancer patients undergoing radical
hysterectomy. Gynecol Oncol. 93:458–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamura T, Tsukamoto N, Tsuruchi N, Saito
T, Matsuyama T, Akazawa K and Nakano H: Multivariate analysis of
the histopathologic prognostic factors of cervical cancer in
patients undergoing radical hysterectomy. Cancer. 69:181–186. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takeda N, Sakuragi N, Takeda M, Okamoto K,
Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H and Fujimoto
S: Multivariate analysis of histopathologic prognostic factors for
invasive cervical cancer treated with radical hysterectomy and
systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol
Scand. 81:1144–1151. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fotiou S, Vlahos N, Kondi-Pafiti A,
Zarganis P, Papakonstantinou K and Creatsas G: Intraoperative gross
assessment of myometrial invasion and cervical involvement in
endometrial cancer: Role of tumor grade and size. Gynecol Oncol.
112:517–520. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lo KW, Cheung TH, Yim SF and Chung TK:
Preoperative hysteroscopic assessment of cervical invasion by
endometrial carcinoma: A retrospective study. Gynecol Oncol.
82:279–282. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haldorsen IS, Berg A, Werner HM, Magnussen
IJ, Helland H, Salvesen OO, Trovik J and Salvesen HB: Magnetic
resonance imaging performs better than endocervical curettage for
preoperative prediction of cervical stromal invasion in endometrial
carcinomas. Gynecol Oncol. 126:413–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guthrie GJ, Charles KA, Roxburgh CS,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McMillan DC, Elahi MM, Sattar N, Angerson
WJ, Johnstone J and McArdle CS: Measurement of the systemic
inflammatory response predicts cancer-specific and non-cancer
survival in patients with cancer. Nutr Cancer. 41:64–69. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ, Dagg K and Scott HR: A prospective longitudinal study
of performance status, an inflammation-based score (GPS) and
survival in patients with inoperable non-small-cell lung cancer. Br
J Cancer. 92:1834–1836. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brown DJ, Milroy R, Preston T and McMillan
DC: The relationship between an inflammation-based prognostic score
(Glasgow Prognostic Score) and changes in serum biochemical
variables in patients with advanced lung and gastrointestinal
cancer. J Clin Pathol. 60:705–708. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glen P, Jamieson NB, McMillan DC, Carter
R, Imrie CW and McKay CJ: Evaluation of an inflammation-based
prognostic score in patients with inoperable pancreatic cancer.
Pancreatology. 6:450–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ramsey S, Lamb GW, Aitchison M, Graham J
and McMillan DC: Evaluation of an inflammation-based prognostic
score in patients with metastatic renal cancer. Cancer.
109:205–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Omichi C, Nakamura K, Haraga J, Masuyama H
and Hiramatsu Y: Glasgow prognostic score is an independent marker
for poor prognosis with all cases of epithelial ovarian cancer.
Cancer Med. 5:1074–1080. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu J, Wang H, Liu CC, Lu Y and Tang H:
The Glasgow Prognostic Score (GPS) is a novel prognostic indicator
in advanced epithelial ovarian cancer: A multicenter retrospective
study. J Cancer Res Clin Oncol. 142:2339–2345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishida T, Nakamura K, Haraga J, Ogawa C,
Kusumoto T, Seki N, Masuyama H, Katayama N, Kanazawa S and
Hiramatsu Y: The Glasgow prognostic score determined during
concurrent chemoradiotherapy is an independent predictor of
survival for cervical cancer. Int J Gynecol Cancer. 25:1306–1314.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Polterauer S, Grimm C, Seebacher V, Rahhal
J, Tempfer C, Reinthaller A and Hefler L: The inflammation-based
Glasgow prognostic score predicts survival in patients with
cervical cancer. Int J Gynecol Cancer. 20:1052–1057. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO Classification of Tumors of Female Reproductive
Organs. Fourth. Lyon, France: IARC Press; pp. 62014
|
|
23
|
Marnell L, Mold C and Du Clos TW:
C-reactive protein: Ligands, receptors and role in inflammation.
Clin Immunol. 117:104–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic
scores based on the systemic inflammatory response in patients with
inoperable non-small-cell lung cancer. Br J Cancer. 89:1028–1030.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Candido J and Hagemann T: Cancer-related
inflammation. J Clin Immunol. 33 Suppl 1:S79–S84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Wezeman M, Zhang X, Lin P, Wang M,
Qian J, Wan B, Kwak LW, Yu L and Yi Q: Human C-reactive protein
binds activating Fcgamma receptors and protects myeloma tumor cells
from apoptosis. Cancer Cell. 12:252–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta D and Lis CG: Pretreatment serum
albumin as a predictor of cancer survival: A systematic review of
the epidemiological literature. Nutr J. 9:692010. View Article : Google Scholar : PubMed/NCBI
|
